Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives.

Rămoiu-Shehada RI, Mușetescu AE, Florescu LM, Florescu A, Ciurea PL

Open source

DOI
10.3390/life16091420
Published
2026 Aug 27
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life16091420,
  title = {Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives.},
  author = {Rămoiu-Shehada RI and Mușetescu AE and Florescu LM and Florescu A and Ciurea PL},
  year = {2026},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life16091420},
  url = {https://doi.org/10.3390/life16091420}
}

RIS

TY  - JOUR
TI  - Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives.
AU  - Rămoiu-Shehada RI
AU  - Mușetescu AE
AU  - Florescu LM
AU  - Florescu A
AU  - Ciurea PL
PY  - 2026
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life16091420
UR  - https://doi.org/10.3390/life16091420
ER  - 

APA

RI, R., AE, M., LM, F., A, F., & PL, C. (2026). Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives.. Life (Basel, Switzerland). https://doi.org/10.3390/life16091420

Source records